Esseim Sharma1, Antony F Chu2. 1. The Warren Alpert Medical School of Brown University, Providence, RI, USA. esseim.sharma@lifespan.org. 2. The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
PURPOSE: Transcatheter aortic valve replacement (TAVR) is an increasingly prevalent therapy in patients with severe symptomatic aortic stenosis. Conduction disturbances requiring permanent pacemaker (PPM) implantation are a known complication of TAVR. This study investigated the progression of cardiac conduction disease in the post-TAVR pacemaker population and identified predictors of post-TAVR right ventricular (RV) pacing dependence. METHODS: Prospectively collected echocardiographic, ECG, and PPM interrogation data of 262 consecutive patients who underwent TAVR with placement of a balloon-expandable valve at one institution from March 2012 to October 2016 were analyzed. RESULTS: A total of 25 patients (11.1%) required post-TAVR PPM implantation. Seventeen patients who received PPMs did not require RV pacing at 30 days. Nine of these 17 patients had no RV pacing requirement within 10 days. Pre-existing right bundle branch block (RBBB) (OR 105.4, 4.52-2458.5, p = 0.0002), bifascicular block (OR 12.50, 1.60-97.65, p = 0.02), intra-procedural complete heart block (OR 12.83, 1.26-130.52, p = 0.03), and QRS duration > 120 ms (OR 70.43, 3.23-1535.22, p = 0.0002) on pre-TAVR ECG were associated with RV pacing dependence at 30 days. CONCLUSIONS: Sixty-eight percent of patients meeting post-procedural guideline indications for PPM did not require RV pacing at 30 days. Fifty-two percent of these patients demonstrated recovery of sinus node function or AV conduction within 10 days post-implant. RBBB, intra-procedural complete heart block, bifascicular block, and QRS duration > 120 ms were associated with RV pacing dependence at 30 days. These findings suggest that post-TAVR conduction disturbances may be acutely reversible in a significant proportion of patients receiving PPM within 10-30 days of implant.
PURPOSE: Transcatheter aortic valve replacement (TAVR) is an increasingly prevalent therapy in patients with severe symptomatic aortic stenosis. Conduction disturbances requiring permanent pacemaker (PPM) implantation are a known complication of TAVR. This study investigated the progression of cardiac conduction disease in the post-TAVR pacemaker population and identified predictors of post-TAVR right ventricular (RV) pacing dependence. METHODS: Prospectively collected echocardiographic, ECG, and PPM interrogation data of 262 consecutive patients who underwent TAVR with placement of a balloon-expandable valve at one institution from March 2012 to October 2016 were analyzed. RESULTS: A total of 25 patients (11.1%) required post-TAVR PPM implantation. Seventeen patients who received PPMs did not require RV pacing at 30 days. Nine of these 17 patients had no RV pacing requirement within 10 days. Pre-existing right bundle branch block (RBBB) (OR 105.4, 4.52-2458.5, p = 0.0002), bifascicular block (OR 12.50, 1.60-97.65, p = 0.02), intra-procedural complete heart block (OR 12.83, 1.26-130.52, p = 0.03), and QRS duration > 120 ms (OR 70.43, 3.23-1535.22, p = 0.0002) on pre-TAVR ECG were associated with RV pacing dependence at 30 days. CONCLUSIONS: Sixty-eight percent of patients meeting post-procedural guideline indications for PPM did not require RV pacing at 30 days. Fifty-two percent of these patients demonstrated recovery of sinus node function or AV conduction within 10 days post-implant. RBBB, intra-procedural complete heart block, bifascicular block, and QRS duration > 120 ms were associated with RV pacing dependence at 30 days. These findings suggest that post-TAVR conduction disturbances may be acutely reversible in a significant proportion of patients receiving PPM within 10-30 days of implant.
Authors: Robert M A van der Boon; Nicolas M Van Mieghem; Dominic A Theuns; Rutger-Jan Nuis; Sjoerd T Nauta; Patrick W Serruys; Luc Jordaens; Ron T van Domburg; Peter P T de Jaegere Journal: Int J Cardiol Date: 2013-01-05 Impact factor: 4.164
Authors: Prateek J Khatri; John G Webb; Josep Rodés-Cabau; Stephen E Fremes; Marc Ruel; Kelly Lau; Helen Guo; Harindra C Wijeysundera; Dennis T Ko Journal: Ann Intern Med Date: 2013-01-01 Impact factor: 25.391
Authors: Alexander D Simms; Andrew J Hogarth; Elizabeth A Hudson; Victoria L Worsnop; Daniel J Blackman; David J O'Regan; Muzahir H Tayebjee Journal: Interact Cardiovasc Thorac Surg Date: 2013-04-25
Authors: George C M Siontis; Peter Jüni; Thomas Pilgrim; Stefan Stortecky; Lutz Büllesfeld; Bernhard Meier; Peter Wenaweser; Stephan Windecker Journal: J Am Coll Cardiol Date: 2014-07-15 Impact factor: 24.094
Authors: Esseim Sharma; Brian McCauley; Dhairyasheel S Ghosalkar; Michael Atalay; Scott Collins; Anshul Parulkar; Wasiq Sheikh; Malik B Ahmed; Antony Chu Journal: Cardiol Res Date: 2020-05-03
Authors: Justine M Ravaux; Michele Di Mauro; Kevin Vernooy; Arnoud W Van't Hof; Leo Veenstra; Suzanne Kats; Jos G Maessen; Roberto Lorusso Journal: JTCVS Open Date: 2021-02-12
Authors: Mohammed Saad; Yannic Klaus; Paul Buhse; Thomas Puehler; Georg Lutter; Hatim Seoudy; Derk Frank Journal: Herzschrittmacherther Elektrophysiol Date: 2021-07-14